Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Centrica ( (GB:CNA) ) has shared an update.
Centrica has disclosed routine share dealings by executive directors Christopher O’Shea and Russell O’Brien under the company’s Share Incentive Plan. The transactions, administered by Equiniti, involved the acquisition of small volumes of partnership and matching shares at prices just above £2.10 per share.
The purchases modestly increase the executives’ equity stakes and reflect ongoing participation in Centrica’s employee share scheme. While financially immaterial in size, such transactions are closely watched by investors as indicators of management alignment with shareholder interests and adherence to market abuse regulations.
The most recent analyst rating on (GB:CNA) stock is a Buy with a £245.00 price target. To see the full list of analyst forecasts on Centrica stock, see the GB:CNA Stock Forecast page.
Spark’s Take on CNA Stock
According to Spark, TipRanks’ AI Analyst, CNA is a Neutral.
Overall score is driven primarily by mid-tier financial performance: strong revenue momentum and consistently positive free cash flow are offset by volatile bottom-line results (net loss in 2025) and a balance sheet that remains only moderately stable. Technicals are mildly supportive with the stock holding above key longer-term moving averages and neutral momentum. Valuation is reasonable with a moderate P/E and dividend yield.
To see Spark’s full report on CNA stock, click here.
More about Centrica
Centrica plc is a UK-based energy company listed on the London Stock Exchange under the ticker CNA. The group supplies energy and related services to customers, and its ordinary shares carry the ISIN GB00B033F229, with its registered office in Windsor, Berkshire.
Average Trading Volume: 18,873,277
Technical Sentiment Signal: Buy
Current Market Cap: £9.57B
Learn more about CNA stock on TipRanks’ Stock Analysis page.

